An antigen-less pro-vaccine for treating autoimmunity
J Immunol. 2025 Apr 24:vkaf068. doi: 10.1093/jimmun/vkaf068. Online ahead of print. ABSTRACT We have designed the first antigen-less pro-vaccine, named 8206, for treating autoimmune diseases. Composed of dexamethasone, rapamycin, and R848 at a mass ratio of 8:20:6, 8206 is a complete tolerogenic adjuvant that acts systemically to form an active vaccine in situ with endogenous … Read more